Cara Therapeutics, Inc. (NASDAQ:CARA – Get Free Report)’s share price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $1.33 and traded as low as $0.82. Cara Therapeutics shares last traded at $0.91, with a volume of 4,300,261 shares. Analysts Set […]
Cara Therapeutics (NASDAQ:CARA – Get Free Report) had its target price lowered by investment analysts at Needham & Company LLC from $6.00 to $5.00 in a report released on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. Other equities analysts have also issued reports about the stock. HC […]
Shares of Cara Therapeutics, Inc. (NASDAQ:CARA – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six brokerages that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have given a buy recommendation to […]
Cara Therapeutics, Inc. (NASDAQ:CARA – Get Free Report) was the recipient of a significant growth in short interest in the month of November. As of November 15th, there was short interest totalling 3,420,000 shares, a growth of 15.2% from the October 31st total of 2,970,000 shares. Currently, 7.4% of the company’s shares are sold short. […]
– Non-dilutive financing agreement with HealthCare Royalty for up to $40 million expected to extend cash runway into 2025 – – Key data readouts for all.